HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 288/5/G1015    most recent 00461.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Bode, L. Articles by Freeze, H. H. Search for Related Content PubMed PubMed Citation Articles by Bode, L. Articles by Freeze, H. H.

MUCOSAL BIOLOGY

Heparan sulfate depletion amplifies TNF--induced protein leakage in an in vitro model of protein-losing enteropathy

¹The Burnham Institute, Glycobiology and Carbohydrate Chemistry Program, La Jolla, California ²Centre for Paediatric Gastroenterology, Royal Free and University College Medical School, Royal Free Campus, London, United Kingdom

Submitted 13 October 2004 ; accepted in final form 10 December 2004

Protein-losing enteropathy (PLE), the excessive loss of plasma proteins through the intestine, often correlates with the episodic loss of heparan sulfate (HS) proteoglycans (HSPG) from the basolateral surface of intestinal epithelial cells. PLE onset is often associated with a proinflammatory state. We investigated whether loss of HS or treatment with the proinflammatory cytokine TNF- directly causes protein leakage and whether a combination of both exacerbates this process. We established the first in vitro model of PLE and measured the flux of albumin/FITC through a monolayer of intestinal HT29 or Caco-2 cells grown on transwells and determined the integrity by transepithelial electrical resistance (TER). Loss of HS from the basolateral surface, either by heparanase digestion or by inhibition of HS synthesis, increased albumin flux 1.58 ± 0.09-fold and reduced TER by 23.4 ± 6.5%. TNF- treatment increased albumin flux 4.04 ± 0.03-fold and reduced TER by 75.7 ± 4.7% but only slightly decreased HS content. The combined effects of HS loss and TNF- treatment were not only additive, but synergistic, with a 7.00 ± 0.11-fold increase in albumin flux and a 83.9 ± 8.1% reduction of TER. Coincubation of TNF- with soluble HS or heparin abolished these synergistic effects. Loss of basolateral HS directly causes protein leakage and amplifies the effects of the proinflammatory cytokine TNF-. Our findings imply that loss of HSPGs renders patients more susceptible to PLE and offer a potential explanation for the favorable response some PLE patients have to heparin therapy.

intestinal protein loss; congenital disorders of glycosylation; Fontan surgery; heparin therapy

This article has been cited by other articles:

				A. M. Ostrow, H. Freeze, and J. Rychik Protein-Losing Enteropathy After Fontan Operation: Investigations Into Possible Pathophysiologic Mechanisms Ann. Thorac. Surg., August 1, 2006; 82(2): 695 - 700. [Abstract] [Full Text] [PDF]